Affinity electrophoresis for studies of mechanisms regulating glycosylation of plasma proteins.

Electrophoresis
A Mackiewicz, I Kushner

Abstract

A model system for studies of mechanisms governing the alterations of glycosylation of plasma glycoproteins was developed. The system employs two human hepatoma cell lines, Hep 3B and Hep G2, as target cells and agarose affinity electrophoresis with lectins for studies of microheterogeneity of alpha 1-protease inhibitor (PI), a model glycoprotein synthesized by hepatocytes. As an example for the application of the system, the effect of cytokines on major microheterogeneity of plasma proteins is demonstrated. The results indicate that interleukin 6, transforming growth factor beta 1 and, to some extent, tumor necrosis factor alpha are directly involved in regulating the pattern of glycosylation of plasma proteins in vitro, but the major effect is obtained by using combinations of interleukin 6, transforming growth factor beta 1, tumor necrosis factor alpha and interleukin 1. In addition, the results underline the dissociation between alteration of gene expression and the changes in the pattern of plasma protein glycosylation.

References

Aug 1, 1986·Analytical Biochemistry·A Mackiewicz, S Mackiewicz
Jul 1, 1987·The Journal of Experimental Medicine·A MackiewiczI Kushner
Jan 1, 1988·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·J Breborowicz
Feb 1, 1989·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·H Baumann
Aug 1, 1989·Electrophoresis·J Breborowicz, A Mackiewicz
Aug 15, 1988·Clinica Chimica Acta; International Journal of Clinical Chemistry·M JezequelG M Durand
Mar 16, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·A MackiewiczS Mackiewicz
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·B M Woloski, G M Fuller
Jan 1, 1972·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·C B Laurell
Sep 1, 1984·Placenta·A MackiewiczJ Breborowicz
Jul 1, 1981·Scandinavian Journal of Immunology·J BreborowiczD Breborowicz
Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·K BridgesR D Klausner
Mar 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J CarlsonT Kjellström
Mar 4, 1982·Biochimica Et Biophysica Acta·L VaughanR W Carrell

❮ Previous
Next ❯

Citations

Aug 7, 1998·Clinical Rheumatology·M SobieskaW Müller
Jun 1, 1995·Molecular Biotechnology·R J LinhardtJ R Fromm
Mar 17, 1999·International Journal of Cardiology·E KaźmierczakK Wiktorowicz
Feb 14, 2002·Journal of Physiological Anthropology and Applied Human Science·D KanikowskaH Tokura
Jun 12, 2009·Electrophoresis·Niels H H Heegaard
Dec 14, 2002·Osteoarthritis and Cartilage·MaryFran SowersLaurie Lachance
Mar 28, 1997·The Journal of Biological Chemistry·J CichyJ Travis
Jul 21, 1995·Annals of the New York Academy of Sciences·K GryskaA Mackiewicz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.